MedPath

PYLERA

PYLERA

Approved
DIN Number

02246962

Drug Class

Human

Market Date

N/A

Company
HC

laboratoires juvise pharmaceuticals

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246962
AIG Number0348802001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BD08 BISMUTH SUBCITRATE,TETRACYCLINE AND METRONIDAZOLE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:30.92
Health Canada Classification

ACTIVE INGREDIENTS (3)

BISMUTH OXIDE (BISMUTH SUBCITRATE POTASSIUM)Active
Strength: 40 MG
Monograph: BISMUTH OXIDE (BISMUTH SUBCITRATE POTASSIUM)
METRONIDAZOLEActive
Strength: 125 MG
Monograph: METRONIDAZOLE
TETRACYCLINE HYDROCHLORIDEActive
Strength: 125 MG
Monograph: TETRACYCLINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.